A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure

A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure

Introduction and Objectives: Most multi-biomarker strategies in acute heart failure (HF) have only measured biomarkers in a single-point time. This study aimed to evaluate the prognostic yielding of NT-proBNP, hsTnT, Cys-C, hs-CRP, GDF15, and GAL-3 in HF patients both at admission and discharge.Meth...

Full description

Bibliographic Details
Main Authors: Jesús Álvarez-García, Álvaro García-Osuna, Miquel Vives-Borrás, Andreu Ferrero-Gregori, Manuel Martínez-Sellés, Rafael Vázquez, José R. González-Juanatey, Miguel Rivera, Javier Segovia, Domingo Pascual-Figal, Ramón Bover, Ramón Bascompte, Juan Delgado, Andrés Grau Sepúlveda, Alfredo Bardají, Félix Pérez-Villa, José Luis Zamorano, Marisa Crespo-Leiro, Pedro Luis Sánchez, Jordi Ordoñez-Llanos, Juan Cinca
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Physiology
Subjects:
biomarker (BM)
panel (C33)
acute heart failure (AHF)
risk stratification
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2021.708890/full

Internet

https://www.frontiersin.org/articles/10.3389/fphys.2021.708890/full

Similar Items